At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Transcutaneous Electrical Nerve Stimulation (TENS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcutaneous Electrical Nerve Stimulation (TENS) Self-applied as Complementary Treatment for Pain and Its Impact on Quality of Life and Sexuality of Women With Deep Endometriosis: Randomized Controlled Trial
In Brief
A clinical study evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Endometriosis. Completed, enrolled 80 participants across 1 site.
Detailed Summary
Objective: to evaluate the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) self-applied for the treatment of pain and the impact of this therapy on quality of life and sexuality of women with deep endometriosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 2016
Enrollment StartJun 2016
Primary CompletionMar 2018
Study CompletionFeb 2019
TodayJul 2026
First PostedMay 11, 2016
Enrollment StartJun 1, 2016
Primary CompletionMar 1, 2018
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.1 years ago
Interventions
Transcutaneous Electrical Nerve Stimulation (TENS)device
Electrotherapy through self-applied device .